Oculis Holding AG (OCS) Invested Capital (2021 - 2025)
Quarterly Invested Capital rose 44.03% to $73.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $73.4 billion through Dec 2025, up 44.03% year-over-year, with the annual reading at $73.4 billion for FY2025, 44.03% up from the prior year.
Oculis Holding AG's Invested Capital history spans 5 years, with the latest figure at $73.4 billion for Q4 2025.
- Invested Capital came in at $73.4 billion for Q4 2025, up from $51.0 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $73.4 billion in Q4 2025 to a low of -$101.7 million in Q4 2022.
- The 5-year median for Invested Capital is $41.3 billion (2023), against an average of $33.1 billion.
- Year-over-year, Invested Capital plummeted 53.87% in 2022 and then skyrocketed 40719.85% in 2023.
- Oculis Holding AG's Invested Capital stood at -$66.1 million in 2021, then tumbled by 53.87% to -$101.7 million in 2022, then surged by 40719.85% to $41.3 billion in 2023, then grew by 23.39% to $51.0 billion in 2024, then skyrocketed by 44.03% to $73.4 billion in 2025.
- Per Business Quant, the three most recent readings for OCS's Invested Capital are $73.4 billion (Q4 2025), $51.0 billion (Q4 2024), and $41.3 billion (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73.43 Bn |
| Dec 31, 2024 | 50.98 Bn |
| Dec 31, 2023 | 41.32 Bn |
| Dec 31, 2022 | -101.72 Mn |
| Dec 31, 2021 | -66.11 Mn |